Natto enzyme may lower heart risk in high cholesterol patients
Disease control
Recruiting now
This study tests whether nattokinase, an enzyme from fermented soy (natto), can reduce inflammation and improve heart health markers in people with high cholesterol. About 48 adults with dyslipidemia will take nattokinase or a placebo for two months. Researchers will measure chan…
Phase: NA • Sponsor: Universidade Federal Fluminense • Aim: Disease control
Last updated May 17, 2026 06:47 UTC